Evidence map›Paper›PMID 33855084›Full record

ArticleBioMed research international2021

Amelioration of Hepatic Encephalopathy Using

Farouk K El-Baz, Rania Elgohary, Abeer Salama

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  3. Article
  4. DietaryFrontiers in veterinary science · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Biology · 2022
    Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Farouk K El-BazPlant Biochemistry Department, National Research Centre (NRC), 33 El Buhouth St., Dokki, Cairo 12622, Egypt.ORCID https://orcid.org/0000-0002-4750-3559
Rania ElgoharyNarcotics, Ergogenics and Poisons Department, National Research Centre (NRC), 33 El Buhouth St., Dokki, Cairo 12622, Egypt.ORCID https://orcid.org/0000-0002-2948-5449
Abeer SalamaPharmacology Department, National Research Centre (NRC), 33 El Buhouth St., Dokki, Cairo 12622, Egypt.ORCID https://orcid.org/0000-0001-9870-5583
National Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic encephalopathy (HE) is a neuropsychiatric disease that is developed as a complication of both acute and chronic liver failure affecting psychomotor dysfunction, memory, and concentration. This study is aimed at evaluating the therapeutic effects of

Indexed as

AmmoniaAnimalsBehavior, AnimalBiomarkersBrainHepatic EncephalopathyHSP27 Heat-Shock ProteinsHyperammonemiaInsulin-Like Growth Factor ILiverMaleMicroalgaeModels, BiologicalOxidative StressPowdersRatsAmmoniaBiomarkersHSP27 Heat-Shock ProteinsHspb1 protein, ratInsulin-Like Growth Factor IPowdersToll-Like Receptor 4

Identifiers

PMID33855084
PMCPMC8021475
OpenAlexW3146488259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.